Clinical trial
Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
NCT00186381 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
- Lead sponsor
- Stanford University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 1995
- Completion date
- March 31, 2007
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood and marrow transplant (bmt), leukemia, leukemia, myelocytic, acute